Ulrich M. Lauer
Ulrich M. Lauer, Prof. Dr. med., completed Human Medicine degree at the University of Erlangen-Nürnberg Medical School, 1982–1988 and the M.D. thesis, 1986–1989, tumor immunology. Lauer completed the postdoc studies in Tumor virology at the Department for Virus Research, the Max-Planck-Institute for Biochemistry, Munich (Martinsried), 1988–1993. Since 1993, Lauer has been a Research Group Leader, University Clinic of Tübingen. Lauer has a Board Certification in internal medicine, 1993–2000, was an Internal Medicine Senior Physician 2001, completed the Internal Medicine Habilitation 2001, has Internal Medicine Board certification in Gastroenterology 2005, was an Associate Professor 2006, was a Coordinator 2006–2013, German Oncolysis Consortium, has a Certificate in Gastrointestinal Oncology (DGVS) 2007, Collaborative Research Center (SFB 773) of the German Research Council (DFG), and was a Project Group Leader and Project Leader, 2008–2012. Lauer received the Fellowship of the German Cancer Aid (Deutsche Krebshilfe), 1988-1989, the Fellowship of the German Research Council (DFG), 1989–1991, the Fellowship of the Max-Planck-Society (MPG), 1991–1993, the Scholarship Award from the Sandoz Foundation for Therapeutic Research, 1994, Scholarship Award from the Center for Interdisciplinary Clinical Research (IZKF), University of Tübingen, 1998, the Scientific lecturing Award from the Medical Faculty, University of Tübingen, 2000, and the Novartis Research Science Award from the International Society on Pediatric Surgical Research, 2005. Lauer is a Member in the American Society for Gene and Cell Therapy (ASGCT) and the German Society for Gene Therapy (DGGT). Lauer's research fields include virotherapy and epigenetic tumor therapy, experimental and translational oncology, patient-individualized virotherapy, oncolytic virus technologies, suicide gene arming of oncolytic viruses, antiangiogenic tumor therapy, and innate-immunity-mediated Tumor Therapy.
Biography Updated on 17 October 2011